Biomarkery choroby przeszczep-przeciw-gospodarzowi – współczesny stan wiedzy i nadzieje na przyszłość

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Acta haematologica Polonica

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ACHAEM.2013.07.006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Aplastic Anemia

  2020cited by this paper
• IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD

  2013cited by this paper
• Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.

  2012influential reference
• Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

  2012cited by this paper
• Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

  2012influential reference
• Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

  2012cited by this paper
• Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

  2011cited by this paper
• Biomarkers of immune activation to screen for severe, acute GVHD

  2011cited by this paper
• Discovery and validation of graft-versus-host disease biomarkers.

  2011cited by this paper
• Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

  2011cited by this paper
• Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.

  2010cited by this paper
• Th17/Treg ratio in human graft-versus-host disease.

  2010cited by this paper
• Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

  2010influential reference
• Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

  2010influential reference
• Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.

  2010cited by this paper
• Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.

  2009cited by this paper
• Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

  2009cited by this paper
• Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.

  2009cited by this paper
• Interleukin-17–Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation

  2009cited by this paper
• Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study

  2009influential reference
• A biomarker panel for acute graft-versus-host disease.

  2009influential reference
• Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

  2009influential reference
• CD 4 + CD 25 high regulatory T cells and CD 4 + CD 69 + T cells in peripheral blood of patients with cutaneous lupus erythematosus

  2009cited by this paper
• Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.

  2008cited by this paper
• Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

  2008cited by this paper
• Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

  2008cited by this paper
• Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

  2008cited by this paper
• Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation.

  2007cited by this paper
• Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

  2007influential reference
• High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

  2007influential reference
• Graft-versus-host disease

  2007cited by this paper
• Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

  2007cited by this paper
• High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

  2007cited by this paper
• Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

  2006cited by this paper
• Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia

  2006cited by this paper
• T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

  2006cited by this paper
• Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.

  2006cited by this paper
• Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

  2006cited by this paper
• Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

  2005influential reference
• Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.

  2005cited by this paper
• Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

  2005cited by this paper
• Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.

  2004cited by this paper
• Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation

  2003cited by this paper
• Chronic graft-versus-host disease: a prospective cohort study.

  2003cited by this paper
• Increased hepatocyte growth factor in serum in acute graft-versus-host disease

  2001cited by this paper
• Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation

  1998cited by this paper
• Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.

  1997cited by this paper
• Th2 cytokines (IL‐4, IL‐10 and IL‐13) and IL‐12 mRNA expression by concanavalin A‐stimulated peripheral blood mononuclear cells during chronic graft‐versus‐host disease

  1996cited by this paper
• TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.

  1995cited by this paper
• Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease.

  1993influential reference
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

  1990cited by this paper

• Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease.

  2017cites this paper